Jena, Germany

Keishi Ishida

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keishi Ishida: Innovator in Biologically Active Compounds

Introduction

Keishi Ishida is a notable inventor based in Jena, Germany. He has made significant contributions to the field of biologically active compounds, particularly in the development of pharmaceutical compositions. His work focuses on addressing critical health issues, including bacterial and fungal infections, as well as cancer.

Latest Patents

Keishi Ishida holds a patent for "Closthioamides, compositions, and methods for treating bacterial or fungal infections or cancer." This invention relates to the field of biologically active compounds and specifically to closthioamides, pharmaceutical compositions comprising these compounds, and their use as antibiotic, antifungal, and/or cytotoxic agents. He has 1 patent to his name, showcasing his innovative approach to tackling serious medical challenges.

Career Highlights

Throughout his career, Ishida has worked with esteemed institutions, including the Leibniz Institute for Natural Product Research and Infection Biology. His research has contributed to advancements in the understanding and treatment of various infections and diseases. His dedication to innovation in the pharmaceutical field has positioned him as a key figure in his area of expertise.

Collaborations

Keishi Ishida has collaborated with notable colleagues such as Swantje Behnken and Hans-Martin Dahse. These partnerships have further enriched his research and development efforts, leading to impactful contributions in the field of biologically active compounds.

Conclusion

In summary, Keishi Ishida is a distinguished inventor whose work in biologically active compounds has the potential to significantly improve treatment options for bacterial and fungal infections, as well as cancer. His innovative spirit and dedication to research continue to inspire advancements in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…